title: Comparable outcome after related or unrelated allogeneic stem cell transplant following reduced conditioning with fludarabine, busulfan and antithymocyte globulin.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Vigouroux
authors.forename: Reza
authors.initials: R
authors.lastname: Tabrizi
authors.forename: Cyril
authors.initials: C
authors.lastname: Melot
authors.forename: Joëlle
authors.initials: J
authors.lastname: Coiffard
authors.forename: Xavier
authors.initials: X
authors.lastname: Lafarge
authors.forename: Gérald
authors.initials: G
authors.lastname: Marit
authors.forename: Krimo
authors.initials: K
authors.lastname: Bouabdallah
authors.forename: Arnaud
authors.initials: A
authors.lastname: Pigneux
authors.forename: Thibaut
authors.initials: T
authors.lastname: Leguay
authors.forename: Marie-Sarah
authors.initials: MS
authors.lastname: Dilhuydy
authors.forename: Anna
authors.initials: A
authors.lastname: Schmitt
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Boiron
authors.forename: Noël
authors.initials: N
authors.lastname: Milpied
mesh_terms: D000328:Adult; D000368:Aged; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002066:Busulfan / Q000627:therapeutic use; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care / Q000379:methods; D012189:Retrospective Studies; D035781:Siblings; D016019:Survival Analysis; D014019:Tissue Donors; D019172:Transplantation Conditioning / Q000379:methods*; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D061349:Unrelated Donors; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000961:Antilymphocyte Serum; D014740:Vidarabine; D002066:Busulfan; C024352:fludarabine